Question 1

Has Sally Bailey received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $358,268 in general payments to Sally Bailey across 731 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Sally Bailey did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Sally Bailey come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Optinose US, Inc.	163	$97,769
Regeneron Healthcare Solutions, Inc.	136	$83,776
Sanofi	125	$80,818
Alk-abello, Inc	105	$45,530
GSK	54	$19,373
Novartis	22	$15,035
Kaleo, Inc.	26	$4,831
Grifols USA, LLC	5	$2,897
AbbVie	9	$2,891
Blueprint Medicines Corporation	11	$2,306
Pfizer	19	$615
AstraZeneca	18	$527
Biocryst US Sales Co., LLC	7	$517
Greer Laboratories, Inc.	2	$300
Genentech USA, Inc.	6	$241
Dermavant Sciences, Inc.	2	$219
Incyte Corporation	5	$97
Amgen	4	$96
ADMA Biomanufacturing LLC	2	$90
Aimmune Therapeutics, Inc.	3	$88
CSL Behring	1	$81
Sanofi US Services Inc.	1	$55
Takeda Pharmaceuticals U.S.A., Inc.	2	$52
Teva Pharmaceuticals USA, Inc.	2	$36
Sanofi-aventis U.S. LLC	1	$24

Sally Bailey

Payments from drug & device makers

Who reported the general payments

How this compares

Other allergy & immunology in Baltimore